Butyrate and mucosal inflammation: New scientific evidence supports clinical observation

Clinical and Translational Gastroenterology

Volumn 6, Issue 8, 2015, Pages

  Cushing, Kelly ^a   Alvarado, David M ^a   Ciorba, Matthew A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUTYRIC ACID; HISTONE DEACETYLASE 3; HYPOXIA INDUCIBLE FACTOR; NICOTINIC ACID; SHORT CHAIN FATTY ACID;

BACTERIAL METABOLISM; COLITIS; DRUG MECHANISM; ENTERITIS; ENZYME INHIBITION; HIGH FIBER DIET; HUMAN; HYPOXIA; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; MACROPHAGE; MUCOSA INFLAMMATION; MUCOSAL IMMUNITY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY;

EID: 84989285235     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2015.34     Document Type: Short Survey

References (8)

1. Harig JM, Soergel KH, Komorowski RA et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989; 320: 23-28.
2. Thibault R, Blachier F, Darcy-Vrillon B et al. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 2010; 16: 684-695.
3. Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-450.
4. Arpaia N, Campbell C, Fan X et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-455.
5. Chang PV, Hao L, Offermanns S et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014; 111: 2247-2252.
6. Singh N, Gurav A, Sivaprakasam S et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40: 128-139.
7. Kelly CJ, Zheng L, Campbell EL et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 2015; 17: 662-671.
8. VanDussen KL, Marinshaw JM, Shaikh N et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 2014; 64: 911-920.